Northwire Canada EditionFriday, October 16, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8% GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8%

Healthcare

Page 46
  1. Mar 18, 2026 · 06:31 · CHS

    Comprehensive Healthcare Systems Advances Strategic Roadmap with New Artificial Intelligence Initiative

    Comprehensive Healthcare Systems Advances Strategic Roadmap with New Artificial Intelligence Initiative

    01
  2. Mar 17, 2026 · 18:26 · VPT

    Ventripoint, FLH expand AI cardiac care to remote areas

    Ventripoint, FLH expand AI cardiac care to remote areas

    02
  3. Mar 17, 2026 · 18:02 · AIDR

    Rocket Doctor AI receives $1.94M from warrant exercise

    Rocket Doctor AI receives $1.94M from warrant exercise

    03
  4. Mar 17, 2026 · 17:55 · OPEN

    Opensesame talks Vector RTO, arranges $3M financing

    Opensesame talks Vector RTO, arranges $3M financing

    04
  5. Mar 17, 2026 · 17:30 · GUD

    Knight wins Anvisa approval for Minjuvi use in Brazil

    Knight wins Anvisa approval for Minjuvi use in Brazil

    05
  6. Mar 17, 2026 · 17:18 · GUD

    Knight Therapeutics seeks OK for new Minjuvi indication

    Knight Therapeutics seeks OK for new Minjuvi indication

    06
  7. Mar 17, 2026 · 17:02 · NPTH

    Neupath Health to release 2025 results March 26

    Neupath Health to release 2025 results March 26

    07
  8. Mar 17, 2026 · 16:59 · KNE

    Kane Biotech highlights data on revyve biofilm action

    Kane Biotech highlights data on revyve biofilm action

    08
  9. Mar 17, 2026 · 15:01 · WELL

    Well Health unit closes acquisitions in Ontario, Quebec

    Well Health unit closes acquisitions in Ontario, Quebec

    09
  10. Mar 17, 2026 · 12:41 · EPRX

    Eupraxia posts 24-week data in high-dose Resolve cohort

    Eupraxia posts 24-week data in high-dose Resolve cohort

    10
  11. Mar 17, 2026 · 11:20 · BNXT

    Bionxt signs LOI for cladribine commercialization

    Bionxt signs LOI for cladribine commercialization

    11
  12. Mar 17, 2026 · 08:07 · VPT

    Ventripoint Partners with First Light Health to Bring AI-Powered Cardiac Diagnostics to Indigenous and Remote Communities

    Ventripoint Partners with First Light Health to Bring AI-Powered Cardiac Diagnostics to Indigenous and Remote Communities

    12
  13. Mar 17, 2026 · 08:00 · AIDR

    Rocket Doctor AI Announces $2.049 Million Gross Proceeds from Warrant Exercises

    Rocket Doctor AI Announces $2.049 Million Gross Proceeds from Warrant Exercises

    13
  14. Mar 17, 2026 · 07:30 · GUD

    Knight Therapeutics Announces Regulatory Supplemental Submission of MINJUVI(TM) (tafasitamab) for Follicular Lymphoma in Argentina and Mexico

    Knight Therapeutics Announces Regulatory Supplemental Submission of MINJUVI(TM) (tafasitamab) for Follicular Lymphoma in Argentina and Mexico

    14
← Newer Older →